[go: up one dir, main page]

EP1126013B2 - Cleaning composition for medical devices - Google Patents

Cleaning composition for medical devices Download PDF

Info

Publication number
EP1126013B2
EP1126013B2 EP01100242A EP01100242A EP1126013B2 EP 1126013 B2 EP1126013 B2 EP 1126013B2 EP 01100242 A EP01100242 A EP 01100242A EP 01100242 A EP01100242 A EP 01100242A EP 1126013 B2 EP1126013 B2 EP 1126013B2
Authority
EP
European Patent Office
Prior art keywords
accordance
cleaning
surfactants
ampho
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP01100242A
Other languages
German (de)
French (fr)
Other versions
EP1126013A1 (en
EP1126013B1 (en
Inventor
Harald Albrecht
Richard Dr. Bloss
Thomas Fehling
Roland Dr. Knieler
Monika Link
Hanns Dr. Pietsch
Dagmar Schulte-Schrepping
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bode Chemie GmbH and Co KG
Original Assignee
Bode Chemie GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7631356&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP1126013(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bode Chemie GmbH and Co KG filed Critical Bode Chemie GmbH and Co KG
Publication of EP1126013A1 publication Critical patent/EP1126013A1/en
Application granted granted Critical
Publication of EP1126013B1 publication Critical patent/EP1126013B1/en
Publication of EP1126013B2 publication Critical patent/EP1126013B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/66Non-ionic compounds
    • C11D1/72Ethers of polyoxyalkylene glycols
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/26Organic compounds containing nitrogen
    • C11D3/33Amino carboxylic acids

Definitions

  • the present invention relates to the use of liquid detergents containing surfactants, corrosion inhibitors and other additives that enhance cleaning for cleaning medical instruments, in particular for cleaning flexible endoscopes by removing X-ray contrast agents.
  • Endoscopes are tubular or tubular instruments used to examine body cavities and hollow organs. They are equipped with an optical system consisting of lens and eyepiece, a lighting device and usually rinsing and suction devices and channels for introducing special instruments.
  • Flexible endoscopes (which are also referred to as fiber endoscopes) are equipped with a fiber optic light guide, which consists of a tightly packed bundle of hair-thin and therefore highly flexible individual fibers. Due to the flexibility of the glass fibers, light and image can be transmitted via virtually any bend.
  • the fiber bundles and the Bowden cables for the movement of the tip channels for flushing and air and a generally larger biopsy and at the same time suction duct are housed.
  • the endoscopy alone, for example, for the removal of tissue samples, but also in combination with other methods, such.
  • ultrasound endoscopic ultrasonography
  • X-ray diagnostics are performed.
  • X-ray contrast images of the gallbladder and the bile ducts and of the pancreatic duct system are commonly used. This is -. B. in the context of an endoscopic retrograde cholangiography (ERC) or an endoscopic retrograde cholangiopancreatography (ERCP) - introduced an X-ray contrast agent under X-ray control in the duct system to be examined.
  • ERP endoscopic retrograde cholangiography
  • ERCP endoscopic retrograde cholangiopancreatography
  • X-ray contrast agents are agents for improving the radiographic representation of body spaces, hollow organs and vessels. They absorb X-rays either weaker (negative X-ray contrast agents) or stronger (positive X-ray contrast agents) than the surrounding body tissue.
  • the radiopaque (i.e., radiopaque) positive X-ray contrast agents contain predominantly high atomic number elements (such as iodine and barium) because their X-ray absorptivity is greater.
  • organic iodine derivatives derived from pyridines or aromatic carboxylic acids are typically used.
  • iodoxamic acid [3,3 '- (4,7,10,13-tetraoxahexadecanedioyldiamino) -bis (2,4,6-triiodobenzoic acid)] and [3,3' - (3,6,9-trioxaundecanedioyldiamino)] bis (2,4,6-trüodbenzoeklare)].
  • Endoscopies mostly take place in microbially colonized areas of the body.
  • a transmission of pathogens by contaminated endoscopy itself and by endoscopic accessories has been proven many times.
  • infections with a long incubation period are very difficult and usually impossible to detect in practice.
  • patients whose illness is dumb or unrecognized come into contact with endoscopes.
  • infections with microorganisms whose transmission takes place through the blood and mucous membranes, such.
  • tuberculosis hepatitis, HIV infections, salmonellosis, Yersinia infections, dysentery and the like.
  • liquid cleaning agents for cleaning of flexible endoscopes which contain surfactants in addition to essentially organic solvents, acids or alkalis, and sometimes also enzymes.
  • surfactants in addition to essentially organic solvents, acids or alkalis, and sometimes also enzymes.
  • the compounds mentioned have some disadvantages:
  • liquid cleaners are relatively effective at removing blood and secretion residues as well as at the separation of fat and other hydrocarbonaceous compounds. However, they are not suitable for completely removing residues of X-ray contrast agents.
  • the object of the invention is therefore to develop a liquid cleaning agent for the removal of X-ray contrast agents, which does not have the disadvantages of the prior art, which thus shows a good cleaning performance at the same time high material compatibility and also for the removal of X-ray contrast agents, such.
  • X-ray contrast agents such as organic, aromatic iodine derivatives, in particular from flexible endoscopes.
  • cleaning agents also dried on sparingly soluble aromatic halogen compounds such.
  • the use of the cleaning agent according to the invention especially in duoendoscopes over which X-ray contrast agents are preferably administered, has a significantly better cleaning performance than the cleaners of the prior art. This greatly improved the microbiological status of duoendoscopes (after subsequent disinfection).
  • the nonionic surfactant or surfactants are selected from the group of alkylethoxylates whose alkyl group is a saturated or unsaturated, straight or branched chain alkyl group having 10 to 18, preferably 12 to 14 carbon atoms, preferably 2 to 15, in particular 5 to 9, per molecule , especially containing 7 ethylene oxide units.
  • alkylethoxylates whose alkyl group is a saturated or unsaturated, straight or branched chain alkyl group having 10 to 18, preferably 12 to 14 carbon atoms, preferably 2 to 15, in particular 5 to 9, per molecule , especially containing 7 ethylene oxide units.
  • isotridecanol ethoxylate and / or fatty alcohol polyglycol ethers are particularly preference.
  • the total amount of nonionic surfactants is selected from the range of 1.0 to 20.0 wt .-%, preferably from 10.0 to 15.0 wt .-%, each based on the total weight of preparations.
  • the pyrrolidonecarboxylic acid (pyroglutamic acid), which is characterized by the following structural formula: used.
  • the total amount of the amino acid is selected from the range of 0.1 to 10.0 wt .-%, preferably from 0.5 to 2.0 wt .-%, each based on the total weight of the preparations.
  • the cleaning agents used according to the invention can be further Amphoteric surfactants included.
  • Amphoteric surfactants are surfactants that possess both acidic and basic hydrophilic groups and thus behave acidic or basic depending on the condition.
  • amphoteric surfactants based on aliphatic polyamines having carboxy, sulfo or phosphono side chains, for example R-NH- (CH 2 ) n -COOH are advantageous.
  • amphoteric surfactants whose alkyl group is a saturated or unsaturated, straight or branched chain alkyl group having 10 to 18, preferably 12 to 14 carbon atoms.
  • amphoteric surfactants from the group of amphopropionates such as. Cocobetainamido amphopropionate, which is characterized by the following structure:
  • the total amount of amphoteric surfactants is selected from the range of 1.0 to 10.0 wt .-%, preferably from 2.0 to 5.0 wt .-%, each based on the total weight of the preparations ,
  • the detergents used according to the invention can be in the form of liquid concentrates and packaged, for example, in dosing bags, so that a use solution can be prepared fresh in each case. It is particularly advantageous if the pH of the concentrate is between 5 and 9.
  • the liquid concentrates are preferably diluted with water to a use solution. Preference is given to the use of working solutions containing 0.5 to 5 wt .-% of cleaning agent according to the invention.
  • the use solution preferably has a pH between 6 and 8 in order to achieve optimal protection of the sensitive material.
  • the cleaning agents used according to the invention can also advantageously contain conventional corrosion inhibitors, such as, for example, benzotriazole, in particular if they can come into contact with metallic surfaces, in particular with non-refined steels or materials of non-ferrous metal alloys, when used. It is preferred to choose the content of one or more corrosion inhibitors between 0.1 and 5 wt .-%, based on the total weight of the formulation.
  • conventional corrosion inhibitors such as, for example, benzotriazole
  • the cleaning agents used according to the invention may advantageously additionally contain complexing agents and / or pH regulators in order to reduce the negative influence of fluctuating water hardness or to ensure that the pH of the cleaning agent is within a range which does not damage the sensitive material.
  • the cleaning agents used according to the invention for such preparations may contain customary preservatives, dyes, fragrances and / or other customary auxiliaries. These contribute in the majority of cases not to the cleaning effect, but serve the storage and aesthetic purposes. However, it is also possible to use those components which develop a (preservative, nourishing effect and at the same time provide for a particular color and / or a pleasant fragrance.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Detergent Compositions (AREA)

Abstract

A liquid cleaning agent for surgical instruments contains a non-ionic tenside and an amino-acid and/or an amino-acid derivative. The non-ionic tenside is selected from the group of alkylethoxylates whose alkyl groups have a saturated or unsaturated, straight or branched chained alkyl group with 10 to 18 pref. 12 to 14 carbon atoms. The fluid system contains amino-acid carboxylic acid and/or glutaminic acid. The non-ionic tenside contains isotri-decanolethoxylate and/or lipid alcohol polyglycol-ether.

Description

Die vorliegende Erfindung betrifft die Verwendung von flüssigen Reinigungsmittel mit einem Gehalt an Tensiden, Korrosionsschutzmitteln und weiteren Zusätzen, die die Reinigung verstärken zur Reinigung von medizinischen Instrumenten, insbesondere zur Reinigung von flexiblen Endoskopen durch Entfernung von Röntgenkontrastmitteln.The present invention relates to the use of liquid detergents containing surfactants, corrosion inhibitors and other additives that enhance cleaning for cleaning medical instruments, in particular for cleaning flexible endoscopes by removing X-ray contrast agents.

Endoskope sind röhren- oder schlauchförmige Instrumente, welche zur Untersuchung von Körperhohlräumen und Hohlorganen verwendet werden. Sie sind mit einem optischen System, bestehend aus Objektiv und Okular, einer Beleuchtungseinrichtung und meist Spül- und Absaugvorrichtungen sowie Kanälen zum Einführen spezieller Instrumente ausgestattet. Flexible Endoskope (welche auch als Fiberendoskope bezeichnet werden) sind mit einem Glasfaserlichtleiter ausgerüstet, welcher aus einem dicht gepackten Bündel aus haarfeinen und deshalb hochflexiblen Einzelfasern besteht. Durch die Flexibilität der Glasfasern können Licht und Bild über praktisch jede beliebige Abwinklung übertragen werden. Zusätzlich zu den Faserbündeln und den Bowdenzügen für die Bewegung der Spitze sind Kanäle für Wasserspülung und Luft sowie ein in der Regel größerer Biopsie- und gleichzeitig Absaugkanal untergebracht.Endoscopes are tubular or tubular instruments used to examine body cavities and hollow organs. They are equipped with an optical system consisting of lens and eyepiece, a lighting device and usually rinsing and suction devices and channels for introducing special instruments. Flexible endoscopes (which are also referred to as fiber endoscopes) are equipped with a fiber optic light guide, which consists of a tightly packed bundle of hair-thin and therefore highly flexible individual fibers. Due to the flexibility of the glass fibers, light and image can be transmitted via virtually any bend. In addition to the fiber bundles and the Bowden cables for the movement of the tip channels for flushing and air and a generally larger biopsy and at the same time suction duct are housed.

Die Endoskopie kann allein, beispielsweise zur Entnahme von Gewebeproben, aber auch in Kombination mit weiteren Methoden, wie z. B. der Ultraschalldiagnostik (Endosonographie) oder der Röntgendiagnostik durchgeführt werden. Gebräuchlich sind beispielsweise Röntgenkontrastdarstellungen der Gallenblase und der Gallengänge sowie des Pankreasgangsystems. Hierbei wird - z. B. im Rahmen einer endoskopischen retrograden Cholangiographie (ERC) bzw. einer endoskopischen retrograden Cholangiopankreatikographie (ERCP) - ein Röntgenkontrastmittel unter Röntgenkontrolle in das zu untersuchende Gangsystem eingebracht.The endoscopy alone, for example, for the removal of tissue samples, but also in combination with other methods, such. As the ultrasound (endoscopic ultrasonography) or X-ray diagnostics are performed. For example, X-ray contrast images of the gallbladder and the bile ducts and of the pancreatic duct system are commonly used. This is -. B. in the context of an endoscopic retrograde cholangiography (ERC) or an endoscopic retrograde cholangiopancreatography (ERCP) - introduced an X-ray contrast agent under X-ray control in the duct system to be examined.

Röntgenköntrastmittel sind Mittel zur Verbesserung der röntgenographischen Darstellung von Körperräumen, Hohlorganen und Gefäßen. Sie absorbieren Röntgenstrahlung entweder schwächer (negative Röntgenkontrastmittel) oder stärker (positive Röntgenkontrastmittel) als das umgebende Körpergewebe. Die radioopaken (d. h. strahlungsundurchlässigen) positiven Röntgenkontrastmittel enthalten vorwiegend Elemente hoher Ordnungszahlen (wie lod und Barium), da deren Absorptionsvermögen für Röntgenstrahlen größer ist. Für die Cholangiographie werden in der Regel organische lod-Derivate, die sich von Pyridinen oder aromatischen Carbonsäuren ableiten, verwendet. Beispiele hierfür sind lodoxaminsäure [3,3'-(4,7,10,13-Tetraoxahexadecandioyldiamino)-bis(2,4,6-triiodbenzoesäure)] und lotroxinsäure [3,3'-(3,6,9-Trioxaundecandioyldiamino)bis(2,4,6-trüodbenzoesäure)].X-ray contrast agents are agents for improving the radiographic representation of body spaces, hollow organs and vessels. They absorb X-rays either weaker (negative X-ray contrast agents) or stronger (positive X-ray contrast agents) than the surrounding body tissue. The radiopaque (i.e., radiopaque) positive X-ray contrast agents contain predominantly high atomic number elements (such as iodine and barium) because their X-ray absorptivity is greater. For cholangiography, organic iodine derivatives derived from pyridines or aromatic carboxylic acids are typically used. Examples of these are iodoxamic acid [3,3 '- (4,7,10,13-tetraoxahexadecanedioyldiamino) -bis (2,4,6-triiodobenzoic acid)] and [3,3' - (3,6,9-trioxaundecanedioyldiamino)] bis (2,4,6-trüodbenzoesäure)].

Endoskopien finden zum Großteil in mikrobiell besiedelten Körperbereichen statt. Die Anzahl endoskopischer Untersuchungen des oberen und unteren Gastrointestinaltraktes und des Tracheobronchialsystems, häufig verbunden mit invasiven Eingriffen, ist sehr hoch. Eine Übertragung von Krankheitserregern durch kontaminierte Endoskopien selbst und durch endoskopisches Zubehör konnte vielfach belegt werden.Endoscopies mostly take place in microbially colonized areas of the body. The number of endoscopic examinations of the upper and lower gastrointestinal tract and the tracheobronchial system, often associated with invasive procedures, is very high. A transmission of pathogens by contaminated endoscopy itself and by endoscopic accessories has been proven many times.

Aus dem Stand der Technik sind die Probleme bei der Reinigung und Desinfektion von Kathetern und Endoskopen bekannt. So beschreibt A. Beck ("Wiederaufbereitung? Untersuchungen zur Wiederverwendung von Kathetern, Führungsdrähten und Angio-Endoskopen", Schnitztor-Verlag GmbH, Konstanz, 1993, 110 - 114) die Schwierigkeiten bezüglich einer ausreichenden Reinigung solcher medizinischer Instrumente aufgrund von abgelagerten Blutbestandteilen und verkrustetem Kontrastmittel.From the prior art, the problems in the cleaning and disinfection of catheters and endoscopes are known. Thus, A. Beck ( "Wiederaufbereitung - Investigations on the reuse of catheters, guidewires and angio-endoscopes", Schnitzor-Verlag GmbH, Konstanz, 1993, 110-114) describes the difficulties with regard to sufficient cleaning of such medical instruments due to deposited blood components and encrusted contrast agent.

Insbesondere Infektionen mit langer Inkubationszeit sind nur sehr schwer und in der Praxis meist gar nicht zu erfassen. Ferner muß damit gerechnet werden, daß auch Patienten, deren Erkrankung stumm oder unerkannt ist, mit Endoskopen in Berührung kommen. Besonderes Gewicht haben in diesem Zusammenhang Infektionen mit Mikroorganismen, deren Übertragung durch das Blut und über die Schleimhäute erfolgt, wie z. B. Tuberkulose, Hepatitis, HIV-Infektionen, Salmonellose, Yersinien-Infektionen, Ruhr und dergleichen mehr.In particular, infections with a long incubation period are very difficult and usually impossible to detect in practice. Furthermore, it must be expected that even patients whose illness is dumb or unrecognized come into contact with endoscopes. Of particular importance in this context are infections with microorganisms whose transmission takes place through the blood and mucous membranes, such. As tuberculosis, hepatitis, HIV infections, salmonellosis, Yersinia infections, dysentery and the like.

Eine Anforderung an die Endoskopie sollte daher die uneingeschränkte Einhaltung aller erforderlichen Schutzmaßnahmen zur Infektionsverhütung sein. Allerdings war die Reinigung und Desinfektion der Fiberendoskope lange Zeit ein Stiefkind der technologischen Entwicklung. So gibt es beispielsweise Probleme mit Restwasser und entsprechender bakterieller Fehlbesiedlung, darüberhinaus lassen sich Endoskope nur schwer trocknen.A requirement for endoscopy should therefore be full compliance with all necessary preventive measures for infection prevention. However, the cleaning and disinfection of fiber endoscopes has long been a stepchild of technological development. For example, there are problems with residual water and corresponding bacterial incorrect colonization, moreover, endoscopes are difficult to dry.

Im Stand der Technik sind z.B. eine Vielzahl von Reinigungs- und Desinfektionsmitteln auf Basis von Glucoprotamin zur Reinigung medizinischer Instrumente beschrieben.In the prior art, e.g. a variety of cleaning and disinfecting agents based on glucoprotamine for cleaning medical instruments described.

So beschreiben B. Meyer und C. Kluin ("Efficacy of glucoprotamin containing disinfectant against different species of atypical mycobacteria" in: Journal of Hospital Infection (1999), 42: 151 - 154 ) ein Desinfektionsmittel, enhaltend Glucoprotamin und nichtionische Tenside, mit einer mykobakteriziden Wirkung. Dieses wie auch das in der Patentanmeldung WO 97/28829 A1 beschriebene Reinigungs- und Desinfektionsmittel auf Basis von Alkylpropylendiamin, Glucoprotamin und Tensiden, sollen geeignet sein zur Reinigung von Endoskopen. In der Patentanmeldung WO 97/28829 A1 ist für das Verfahren zur Reinigung und Desinfektion medizinischer Instrumente angegeben, dass diese bei einer Temperatur von 55°C - 65°C durchgeführt wird.So describe B. Meyer and C. Kluin ("Efficacy of glucoprotamin containing disinfectant against different species of atypical mycobacteria" in: Journal of Hospital Infection (1999), 42: 151-154 ) a disinfectant containing glucoprotamine and nonionic surfactants having a mycobactericidal activity. This as well as in the patent application WO 97/28829 A1 described cleaning and disinfecting agents based on alkylpropylenediamine, glucoprotamine and surfactants, should be suitable for cleaning endoscopes. In the patent application WO 97/28829 A1 For the procedure for cleaning and disinfecting medical instruments, it is stated that this is carried out at a temperature of 55 ° C - 65 ° C.

Ein weiteres Glucoprotamin- und Tensid-haltiges Mittel zur Instrumentendesinfektion und -reinigung ist in einer Broschüre der Firma Henkel zu dem Produkt "Sekusept®Plus", veröffentlicht im Oktober 1992, beschrieben.Another glucoprotamin- and surfactant-containing agent for instrument disinfection and cleaning is described in a brochure from Henkel on the product "Sekusept®Plus", published in October 1992.

Neben Glucoprotamin-basierten Reinigungs- und Desinfektionsmitteln kennt der Stand der Technik zur Reinigung von Gegenständen aus medizinischen Einrichtungen, wie medizinische Instrumente, solche auf Basis anderer Wirkstoffe. In der Patentanmeldung WO 91/13965 A1 etwa ist ein Reinigungs- und Desinfektionsmittel, enthaltend Glutaminsäurederivate, quartäre Ammoniumverbindungen und Tenside, offenbart.In addition to glucoprotamine-based cleaning and disinfecting agents, the state of the art for cleaning articles from medical facilities, such as medical instruments, knows those based on other active ingredients. In the patent application WO 91/13965 A1 for instance, a cleaning and disinfecting agent containing glutamic acid derivatives, quaternary ammonium compounds and surfactants is disclosed.

Daher muß im Vorfeld einer endoskopischen Untersuchung nicht nur die Übertragung von Mikroorganismen, die von Patienten stammen, verhindert werden, sondern es sollte ferner ein besonderes Augenmerk auf Krankheitserreger aus Spülwasser oder stagnierendem Wasser gerichtet werden.Therefore, in advance of an endoscopic examination, not only the transmission of microorganisms derived from patients must be prevented, but also a special attention should be paid to pathogens from rinsing water or stagnant water.

Der Stand der Technik kennt flüssige Reinigungsmittel zur Reinigung von flexiblen Endoskopen, welche neben Tensiden im wesentlichen organische Lösemittel, Säuren oder Laugen sowie teilweise auch Enzyme enthalten. Allerdings weisen die genannten Verbindungen einige Nachteile auf:The prior art knows liquid cleaning agents for cleaning of flexible endoscopes, which contain surfactants in addition to essentially organic solvents, acids or alkalis, and sometimes also enzymes. However, the compounds mentioned have some disadvantages:

Lösemittel, Säuren und Laugen sind zwar von ihrer Wirksamkeit her zur Reinigung prinzipiell geeignet, haben aber den Nachteil, daß sie für das empfindliche Material zu aggressiv sind und die Endoskope dementsprechend beschädigen können.Although solvents, acids and alkalis are in principle suitable for their effectiveness for cleaning, but have the disadvantage that they are too aggressive for the sensitive material and can damage the endoscope accordingly.

Der Umgang mit enzymhaltigen Reinigern ist aus Arbeitssicherheitsgründen problematisch, da diese als sensibilisierende Stoffe und dementsprechend gesundheitsschädlich eingestuft werden, weshalb z. B. Berührungen mit der Haut vermieden werden sollten.The handling of enzyme-containing cleaners is problematic for safety reasons, since these are classified as sensitizing substances and accordingly harmful to health, which is why z. B. Skin contact should be avoided.

Die flüssigen Reinigungsmittel des Standes der Technik sind bei der Entfernung von Blut- und Sekretresten sowie bei der Ablösung von Fett und anderen kohlenwasserstoffhaltigen Verbindungen relativ gut wirksam. Allerdings eignen sie sich nicht, um Reste von Röntgenkontrastmitteln vollständig zu entfernen.The prior art liquid cleaners are relatively effective at removing blood and secretion residues as well as at the separation of fat and other hydrocarbonaceous compounds. However, they are not suitable for completely removing residues of X-ray contrast agents.

Bereits geringste Mengen zurückgebliebenes Röntgenkontrastmittel schließen Bakterien in den Endoskopkanälen ein, die mit den üblichen Desinfektionsmitteln dann nicht mehr vollständig beseitigt werden können. Bei regelmäßigem Einsatz flexibler Endoskope in der Praxis baut sich so im Laufe der Zeit auf der Innenseite der Kanäle ein zunehmender Film des Röntgenkontrastmittels und weiterer Rückstände auf, was zur Folge haben kann, daß das mikrobiologische Ergebnis selbst nach der an die Reinigung anschließenden Desinfektion nicht mehr befriedigend ist.Even the smallest amounts of remaining X-ray contrast media include bacteria in the endoscope channels, which can then no longer be completely eliminated with the usual disinfectants. With regular use of flexible endoscopes in practice builds up over time on the inside of the channels an increasing film of the X-ray contrast agent and other residues, which may result in that the microbiological result is no longer satisfactory, even after the disinfection subsequent to the cleaning.

Für die Patienten bedeutet dies ein erhöhtes Infektionsrisiko und stellt dementsprechend eine erhebliche Gefährdung dar. Zum Schutz vor Infektionen bleibt dann nur noch die Möglichkeit einer Reparatur, was zum einen aufwendig und zum anderen teuer ist.For the patients, this means an increased risk of infection and therefore represents a significant threat. To protect against infection then remains only the possibility of repair, which is both expensive and expensive.

Aufgabe der Erfindung war es daher, ein flüssiges Reinigungsmittel zur Entfernung von Röntgenkontrastmitteln zu entwickeln, das die Nachteile des Standes der Technik nicht aufweist, welches also eine gute Reinigungsleistung bei zugleich hoher Materialverträglichkeit zeigt und sich auch zur Entfernung von Röntgenkontrastmitteln, wie z. B. organischen, aromatischen lod-Derivaten, insbesondere aus flexiblen Endoskopen eignet.The object of the invention is therefore to develop a liquid cleaning agent for the removal of X-ray contrast agents, which does not have the disadvantages of the prior art, which thus shows a good cleaning performance at the same time high material compatibility and also for the removal of X-ray contrast agents, such. As organic, aromatic iodine derivatives, in particular from flexible endoscopes.

Es wurde nun überraschend gefunden, daß alle diese Aufgaben gelöst werden durch die Verwendung von flüssigen Reinigungsmitteln, welche

  • ■ mindestens ein nichtionisches Tensid und
  • ■ Pyrrolidoncarbonsäure
enthalten, zur Reinigung empfindlicher medizinischer Instrumente, flexibler Endoskope und empfindlicher medizinischer Oberflächen durch Entfernung von Röntgenkontrastmitteln.It has now surprisingly been found that all these objects are achieved by the use of liquid detergents, which
  • ■ at least one nonionic surfactant and
  • ■ pyrrolidonecarboxylic acid
For cleaning delicate medical instruments, flexible endoscopes and delicate medical surfaces by removing X-ray contrast agents.

Es war insbesondere überraschend, daß die erfindungsgemäß verwendeten Reinigungsmittel besser und schonender reinigen als die Zubereitungen des Standes der Technik und daß durch diese verbesserte Reinigung bei den überprüften flexiblen Endoskopen das mikrobiologische Problem des Standes der Technik wesentlich verringert werden konnte.It was particularly surprising that the cleaning agents used according to the invention clean better and more gently than the preparations of the prior art and that the microbiological problem of the prior art could be substantially reduced by this improved cleaning in the tested flexible endoscopes.

Erstaunlicherweise lassen sich durch die erfindungsgemäße Verwendung der Reinigungsmittel auch angetrocknete schwerlösliche aromatische Halogenverbindungen, wie z. B. Röntgenkontrastmittelrückstände, vollständig von den Oberflächen ablösen. Durch die erfindungsgemäß Verwendung des Reinigungsmittel sind flexible Endoskope auch nach Monaten ständigen Einsatzes in der Praxis mikrobiologisch immer noch einwandfrei. Dadurch wird die Sicherheit der Patienten wesentlich erhöht und die Lebensdauer dieser hochwertigen medizinischen Geräte verlängert.Surprisingly, by the inventive use of cleaning agents also dried on sparingly soluble aromatic halogen compounds such. B. X-ray contrast agent residues, completely detach from the surfaces. Due to the use of the cleaning agent according to the invention, flexible endoscopes are still microbiologically immaculate even after months of constant use in practice. This significantly increases patient safety and extends the life of these high quality medical devices.

So konnte beispielsweise nachgewiesen werden, daß die erfindungsgemäß Verwendung des Reinigungsmittel besonders bei Duoendoskopen, über die Röntgenkontrastmittel bevorzugt verabreicht werden, eine im Vergleich zu den Reinigern des Standes der Technik wesentlich bessere Reinigungsleistung haben. Hierdurch konnte der mikrobiologische Status der Duoendoskope (nach anschließender Desinfektion) stark verbessert werden.For example, it has been demonstrated that the use of the cleaning agent according to the invention, especially in duoendoscopes over which X-ray contrast agents are preferably administered, has a significantly better cleaning performance than the cleaners of the prior art. This greatly improved the microbiological status of duoendoscopes (after subsequent disinfection).

Erfindungsgemäß vorteilhaft werden das oder die nichtionische Tenside gewählt aus der Gruppe der Alkylethoxylate, deren Alkylgruppe eine gesättigte oder ungesättigte, geradoder verzweigtkettige Alkylgruppe mit 10 bis 18, vorzugsweise 12 bis 14 Kohlenstoffatomen ist, wobei sie vorzugsweise pro Molekül 2 bis 15, insbesondere 5 bis 9, speziell 7 Ethylenoxideinheiten enthalten. Ganz besonders bevorzugt sind Isotridecanolethoxylat und/oder Fettalkoholpolyglykolether.According to the invention, the nonionic surfactant or surfactants are selected from the group of alkylethoxylates whose alkyl group is a saturated or unsaturated, straight or branched chain alkyl group having 10 to 18, preferably 12 to 14 carbon atoms, preferably 2 to 15, in particular 5 to 9, per molecule , especially containing 7 ethylene oxide units. Very particular preference is given to isotridecanol ethoxylate and / or fatty alcohol polyglycol ethers.

Vorteilhaft wird die Gesamtmenge an nichtionischen Tensiden (eine oder mehrere Verbindungen) aus dem Bereich von 1,0 bis 20,0 Gew.-%, vorzugsweise von 10,0 bis 15,0 Gew.-% gewählt, jeweils bezogen auf das Gesamtgewicht der Zubereitungen.Advantageously, the total amount of nonionic surfactants (one or more compounds) is selected from the range of 1.0 to 20.0 wt .-%, preferably from 10.0 to 15.0 wt .-%, each based on the total weight of preparations.

Erfindungsgemäß wird die Pyrrolidoncarbonsäure (Pyroglutaminsäure), welche sich durch die folgende Strukturformel auszeichnet:

Figure imgb0001
eingesetzt.According to the invention, the pyrrolidonecarboxylic acid (pyroglutamic acid), which is characterized by the following structural formula:
Figure imgb0001
used.

Vorteilhaft wird die Gesamtmenge der Aminosäure aus dem Bereich von 0,1 bis 10,0 Gew.-%, vorzugsweise von 0,5 bis 2,0 Gew.-% gewählt, jeweils bezogen auf das Gesamtgewicht der Zubereitungen.Advantageously, the total amount of the amino acid is selected from the range of 0.1 to 10.0 wt .-%, preferably from 0.5 to 2.0 wt .-%, each based on the total weight of the preparations.

In einer besonders vorteilhaften Ausführungsform können die erfindungsgemäß verwendeten Reinigungsmittel ferner Amphotenside enthalten. Amphotenside sind Tenside, die sowohl saure als auch basische hydrophile Gruppen besitzen und sich also je nach Bedingung sauer oder basisch verhalten. Vorteilhaft im Sinne der vorliegenden Erfindung sind beispielsweise Amphotenside auf der Basis von aliphatischen Polyaminen mit Carboxy-, Sulfo- oder Phosphono-Seitenketten, wie beispielsweise R-NH-(CH2)n-COOH.In a particularly advantageous embodiment, the cleaning agents used according to the invention can be further Amphoteric surfactants included. Amphoteric surfactants are surfactants that possess both acidic and basic hydrophilic groups and thus behave acidic or basic depending on the condition. For the purposes of the present invention, for example, amphoteric surfactants based on aliphatic polyamines having carboxy, sulfo or phosphono side chains, for example R-NH- (CH 2 ) n -COOH, are advantageous.

Erfindungsgemäß bevorzugt sind z. B. Amphotenside, deren Alkylgruppe eine gesättigte oder ungesättigte, gerad- oder verzweigtkettige Alkylgruppe mit 10 bis 18, vorzugsweise 12 bis 14 Kohlenstoffatomen ist.According to the invention are preferred z. As amphoteric surfactants whose alkyl group is a saturated or unsaturated, straight or branched chain alkyl group having 10 to 18, preferably 12 to 14 carbon atoms.

Insbesondere vorteilhaft sind ferner Amphotenside aus der Gruppe der Amphopropionate, wie z. B. das Cocobetainamido Amphopropionat, welches sich durch die folgende Struktur auszeichnet:

Figure imgb0002
Also particularly advantageous are amphoteric surfactants from the group of amphopropionates, such as. Cocobetainamido amphopropionate, which is characterized by the following structure:
Figure imgb0002

Vorteilhaft wird die Gesamtmenge an Amphotensiden (eine oder mehrere Verbindungen) aus dem Bereich von 1,0 bis 10,0 Gew.-%, vorzugsweise von 2,0 bis 5,0 Gew.-% gewählt, jeweils bezogen auf das Gesamtgewicht der Zubereitungen.Advantageously, the total amount of amphoteric surfactants (one or more compounds) is selected from the range of 1.0 to 10.0 wt .-%, preferably from 2.0 to 5.0 wt .-%, each based on the total weight of the preparations ,

Die erfindungsgemäß verwendeten Reinigungsmittel können in Form von flüssigen Konzentraten vorliegen und beispielsweise in Dosierbeutel abgepackt werden, so daß eine Gebrauchslösung jeweils frisch angesetzt werden kann. Es ist insbesondere vorteilhaft, wenn der pH-Wert des Konzentrates zwischen 5 und 9 liegt. Die flüssigen Konzentrate werden vorzugsweise mit Wasser zu einer Gebrauchslösung verdünnt. Bevorzugt ist die Verwendung von Gebrauchslösungen, die 0,5 bis 5 Gew.-% an erfindungsgemäßen Reinigungsmittel enthalten. Die Gebrauchslösung hat vorzugsweise einen pH-Wert zwischen 6 und 8, um eine optimale Schonung des empfindlichen Materials zu erreichen.The detergents used according to the invention can be in the form of liquid concentrates and packaged, for example, in dosing bags, so that a use solution can be prepared fresh in each case. It is particularly advantageous if the pH of the concentrate is between 5 and 9. The liquid concentrates are preferably diluted with water to a use solution. Preference is given to the use of working solutions containing 0.5 to 5 wt .-% of cleaning agent according to the invention. The use solution preferably has a pH between 6 and 8 in order to achieve optimal protection of the sensitive material.

Vorteilhaft ist es, die Verdünnung so durchzuführen, daß der Gehalt der einzelnen Substanzen in der Gebrauchslösung wie folgt ist:

  • ■ nichtionische Tenside: zwischen 0,005 und 1 Gew.-%
  • ■ Aminosäure: zwischen 0,0005 und 0,5 Gew.-%
  • ■ Amphotenside: zwischen 0,005 und 0,5 Gew.-%
It is advantageous to carry out the dilution in such a way that the content of the individual substances in the working solution is as follows:
  • ■ nonionic surfactants: between 0.005 and 1% by weight
  • ■ Amino acid: between 0.0005 and 0.5 wt .-%
  • Amphoteric surfactants: between 0.005 and 0.5% by weight

Die erfindungsgemäß verwendeten Reinigungsmittel können ferner vorteilhaft zusätzlich übliche Korrosionsinhibitoren, wie beispielsweise Benzotriazol, enthalten, insbesondere falls sie bei ihrer Anwendung mit metallischen Oberflächen, insbesondere mit nicht veredelten Stählen oder Werkstoffen aus Buntmetallegierungen, in Berührung kommen können. Es wird bevorzugt, den Gehalt an einem oder mehreren Korrosionsinhibitoren zwischen 0,1 und 5 Gew.-%, bezogen auf das Gesamtgewicht der Formulierung, zu wählen.The cleaning agents used according to the invention can also advantageously contain conventional corrosion inhibitors, such as, for example, benzotriazole, in particular if they can come into contact with metallic surfaces, in particular with non-refined steels or materials of non-ferrous metal alloys, when used. It is preferred to choose the content of one or more corrosion inhibitors between 0.1 and 5 wt .-%, based on the total weight of the formulation.

Die erfindungsgemäß verwendeten Reinigungsmittel können darüberhinaus vorteilhaft zusätzlich Komplexbildner und/oder pH-Regulatoren enthalten, um den negativen Einfluß schwankender Wasserhärte zu reduzieren bzw. um zu gewährleisten, daß der pH-Wert des Reinigungsmittels in einem Bereich liegt, der das empfindliche Material nicht schädigt.In addition, the cleaning agents used according to the invention may advantageously additionally contain complexing agents and / or pH regulators in order to reduce the negative influence of fluctuating water hardness or to ensure that the pH of the cleaning agent is within a range which does not damage the sensitive material.

Zusätzlich zu den vorstehend genannten Komponenten können die erfindungsgemäß verwendeten Reinigungsmittel für derartige Zubereitungen übliche Konservierungsstoffe, Farbstoffe, Duftstoffe und/oder andere übliche Hilfsstoffe enthalten. Diese tragen in der Mehrzahl der Fälle nicht zur reinigenden Wirkung bei, sondern dienen der Lagerbarkeit sowie ästhetischen Zwecken. Es ist jedoch auch möglich, solche Komponenten zu verwenden, die eine (konservierende, pflegende Wirkung entfalten und dabei gleichzeitig für eine bestimmte Farbe und/oder einen angenehmen Duft sorgen.In addition to the abovementioned components, the cleaning agents used according to the invention for such preparations may contain customary preservatives, dyes, fragrances and / or other customary auxiliaries. These contribute in the majority of cases not to the cleaning effect, but serve the storage and aesthetic purposes. However, it is also possible to use those components which develop a (preservative, nourishing effect and at the same time provide for a particular color and / or a pleasant fragrance.

Die jeweils einzusetzenden Mengen an derartigen Trägerstoffen und Parfüm können in Abhängigkeit von der Art des jeweiligen Produktes vom Fachmann durch einfaches Ausprobieren leicht ermittelt werden.The amounts of such carriers and perfume to be used in each case can easily be determined by the skilled person by simple trial and error, depending on the nature of the particular product.

Die folgenden Beispiele dienen dazu, die Erfindung zu beschreiben, selbstverständlich ohne daß beabsichtigt ist, die Erfindung auf diese Beispiele zu beschränken. Alle Mengenangaben, Anteile und Prozentanteile sind, soweit nicht anders angegeben, auf das Gewicht und die Gesamtmenge bzw. auf das Gesamtgewicht der Zubereitungen bezogen.The following examples serve to describe the invention, of course, without intending to limit the invention to these examples. All amounts, proportions and percentages are, unless otherwise stated, on the weight and the total amount or on the total weight of the preparations based.

Beispiele:Examples: Beispiel 1:Example 1:

5 %5% Pyrrolidoncarbonsäurepyrrolidone 5 %5% Isotridecanolethoxylatisotridecanol 5 %5% FettalkoholpolyglykoletherFettalkoholpolyglykolether 3 %3% Cocobetainamido AmphopropionatCocobetainamido amphopropionate 1 %1 % Korrosionsschutzcorrosion protection 10 %10% Glykolglycol 1 %1 % pH-RegulatorpH regulator Restrest Wasserwater

Es wird ein pH-Wert von 8 eingestellt.It is set to a pH of 8.

Beispiel 2:Example 2:

7,5 %7.5% Pyrrolidoncarbonsäurepyrrolidone 5 %5% Isotridecanolethoxylatisotridecanol 5 %5% FettalkoholpolyglykoletherFettalkoholpolyglykolether 1 %1 % Korrosionsschutzcorrosion protection 10 %10% Alkoholealcohols 1 %1 % pH-RegulatorpH regulator 3 %3% Komplexbildnercomplexing Restrest Wasserwater

Es wird ein pH-Wert von 8 eingestellt.It is set to a pH of 8.

Beispiel 3:Example 3:

1 %1 % Pyrrolidoncarbonsäurepyrrolidone 6 %6% Isotridecanolethoxylatisotridecanol 6 %6% FettalkoholpolyglykoletherFettalkoholpolyglykolether 2,25 %2.25% Cocobetainamido AmphopropionatCocobetainamido amphopropionate 1 %1 % Korrosionsschutzcorrosion protection 10 %10% Glykolglycol 2 %2% pH-RegulatorpH regulator 3 %3% Komplexbildnercomplexing Restrest Wasserwater

Es wird ein pH-Wert von 8 eingestellt.It is set to a pH of 8.

Mit einem flüssigen Reinigungsmittel gemäß Beispielrezeptur 3 wurde ein Anwendungstest durchgeführt. Dazu wurden 129 Duoendoskope mit einem Reinigungsmittel des Standes der Technik (enzymatischer Reiniger) und 97 Duoendoskope mit dem erfindungsgemäß zu verwenden dem Reinigungsmittel jeweils gereinigt und anschließend desinfiziert; danach wurde der mikrobiologische Status der Geräte überprüft. Es ergaben sich die folgenden Ergebnisse: eR1 Beispiel 32 geprüfte Duoendoskope 129 97 mikrobiologisch einwandfrei 94 91 mikrobiologisch nicht einwandfrei 35 6 1 enzymatischer Reiniger
2 Reinigungsmittel gemäß Beispielrezeptur 3
An application test was carried out with a liquid detergent according to example formulation 3. For this purpose, 129 duoendoscopes were cleaned with a cleaning agent of the prior art (enzymatic cleaner) and 97 duoendoscopes with the cleaning agent to be used according to the invention and then disinfected; Thereafter, the microbiological status of the devices was checked. The results were as follows: eR 1 Example 3 2 tested duoendoscopes 129 97 microbiologically perfect 94 91 microbiologically not perfect 35 6 1 enzymatic cleaner
2 detergent according to example recipe 3

Claims (10)

  1. Use of liquid cleaners that contain at least one nonionic surfactant and pyrrolidone carboxylic acid, for the cleaning of medical instruments, flexible endoscopes and surfaces in medical use, by removing X-ray contrast enhancing agents.
  2. Use in accordance with Claim 1, characterised in that the nonionic surfactant or surfactants is, or are chosen from a group of alkyl ethoxylates with an alkyl group that is a saturated or unsaturated, straight or branched chain alkyl group with 10 to 18, preferably 12 carbon atoms.
  3. Use in accordance with one of claims 1 or 2, characterised in that the cleaner contains isotridecanol ethoxylate and/or fatty alcohol polyglycol ether.
  4. Use in accordance with one of claims 1 or 3, characterised in that the cleaner contains at least one ampho-surfactant(s) as (a) further contituent(s).
  5. Use in accordance with Claim 4, characterised in that the nonionic surfactant or surfactants is, or are chosen from the group of ampho-surfactants with an alkyl group that is a saturated or unsaturated, straight or branched chain alkyl group with 10 to 18, preferably 12 carbon atoms.
  6. Use in accordance with one of claims 4 or 5, characterised in that it contains cocoamido betain ampho-proprionate as the ampho-surfactant
  7. Use in accordance with one of claims 4 to 6, characterised in that the quantity of ampho-surfactant (one or several compounds) is chosen from the range of 1.0 to 10.0 % w/w, preferably 2.0 to 5% w/w, in each case relative to the total weight of the preparations.
  8. Use in accordance with one of claims 1 to 7, characterised in that the cleaner contains one or several nonionic surfactants in a quantity of 1.0 to 20.0 % w/w, preferably 10.0 to 15% w/w, in each case relative to the total weight of the preparations.
  9. Use in accordance with one of claims 1 to 8, characterised in that the cleaner contains pyrrolidone carboxylic acid in a quantity of 0.1 to 10.0 % w/w, in each case relative to the total weight of the preparations.
  10. Use in accordance with one of claims 1 to 9, characterised in that the cleaner is provided in the form of a concentrate which is diluted with water before use as a working solution.
EP01100242A 2000-02-17 2001-01-03 Cleaning composition for medical devices Expired - Lifetime EP1126013B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10007323 2000-02-17
DE10007323A DE10007323A1 (en) 2000-02-17 2000-02-17 Detergent for medical instruments

Publications (3)

Publication Number Publication Date
EP1126013A1 EP1126013A1 (en) 2001-08-22
EP1126013B1 EP1126013B1 (en) 2005-01-19
EP1126013B2 true EP1126013B2 (en) 2013-03-27

Family

ID=7631356

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01100242A Expired - Lifetime EP1126013B2 (en) 2000-02-17 2001-01-03 Cleaning composition for medical devices

Country Status (3)

Country Link
EP (1) EP1126013B2 (en)
AT (1) ATE287442T1 (en)
DE (2) DE10007323A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102014003484A1 (en) 2014-03-14 2015-09-17 Bode Chemie Gmbh Cleaner for inanimate surfaces with special effectiveness against mucus, secretions, blood and biofilms

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0156275A2 (en) 1984-03-24 1985-10-02 Henkel Kommanditgesellschaft auf Aktien Antimicrobially active substances, their preparation and their use
WO1997028829A1 (en) 1996-02-05 1997-08-14 Henkel-Ecolab Gmbh & Co. Ohg Process for cleaning and disinfecting sensitive medical instruments

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4007758A1 (en) * 1990-03-12 1991-09-19 Henkel Kgaa MEANS AND METHODS FOR CLEANING AND DISINFECTING OBJECTS FROM MEDICAL EQUIPMENT IN AUTOMATED EQUIPMENT
DE4234070A1 (en) * 1992-10-09 1994-04-14 Henkel Ecolab Gmbh & Co Ohg Cleaning disinfectant
DE4324396A1 (en) * 1993-07-21 1995-01-26 Henkel Kgaa Detergents with high wettability
JP3686434B2 (en) * 1993-10-01 2005-08-24 千寿製薬株式会社 Stabilizing method for contact lenses
JPH0812572A (en) * 1994-07-01 1996-01-16 Kosakai:Kk Therapeutic agent for dermatomycosis
DE4433071C1 (en) * 1994-09-16 1995-12-21 Henkel Kgaa Mild detergent mixtures
US5576284A (en) * 1994-09-26 1996-11-19 Henkel Kommanditgesellschaft Auf Aktien Disinfecting cleanser for hard surfaces
GB9501285D0 (en) * 1995-01-24 1995-03-15 Jeyes Group Plc Cleansing compositions
GB2321252A (en) * 1997-01-16 1998-07-22 Reckitt & Colman Inc Carpet cleaning compositions
ATE262575T1 (en) * 1997-03-12 2004-04-15 Showa Denko Kk CLEANING SUPPLIES
JP4104704B2 (en) * 1997-10-01 2008-06-18 シスメックス株式会社 Cleaning agent for automatic analyzer
JP4061420B2 (en) * 1998-07-03 2008-03-19 昭和電工株式会社 Liquid detergent composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0156275A2 (en) 1984-03-24 1985-10-02 Henkel Kommanditgesellschaft auf Aktien Antimicrobially active substances, their preparation and their use
WO1997028829A1 (en) 1996-02-05 1997-08-14 Henkel-Ecolab Gmbh & Co. Ohg Process for cleaning and disinfecting sensitive medical instruments

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Sekusept Plus-Pluspunkte über pluspunkte in der instrumenten-desinfektion", HENKEL HYGIENE GMBH GV-PHARMADIENST, 1 October 1992 (1992-10-01), DÜSSELDORF, pages 1 - 4
MEYER B. ET ALL: "Efficacy of glucoprotamin containing disinfectants against different species of atypical mycobacteria", HOSPITAL INFECTION, no. 42, 1999, pages 151 - 154

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102014003484A1 (en) 2014-03-14 2015-09-17 Bode Chemie Gmbh Cleaner for inanimate surfaces with special effectiveness against mucus, secretions, blood and biofilms

Also Published As

Publication number Publication date
DE50105092D1 (en) 2005-02-24
EP1126013A1 (en) 2001-08-22
DE10007323A1 (en) 2001-08-23
ATE287442T1 (en) 2005-02-15
EP1126013B1 (en) 2005-01-19

Similar Documents

Publication Publication Date Title
DE69512841T2 (en) Skin disinfection formulation
DE69524631T2 (en) SYNERGISTIC DISINFECTION AND DETERGENT COMBINATION FOR THE DECONTAMINATION OF A BIOFILM COATED SURFACE
DE602004008454T2 (en) CLEANING AND DECONTAMINATION FORMULAS FOR SURFACES CONTAMINATED WITH PRENINE INFECTED MATERIAL
DE69832601T2 (en) ALKYLPOLYGLYCOSIDE-BASED, PSEUDOMONAS MICRO-ORGANISMS EFFECTIVE DISINFECTANT
DE69523161T2 (en) SALT SOLUTION FOR THE TREATMENT OF CONTACT LENSES
DE69714018T2 (en) QUICK-ACTING CHEMICAL STERILIZER
DE69608507T2 (en) Procedures for cleaning and disinfecting contact lenses
EP1470211B1 (en) Cleaning and disinfection of surgical and medical instruments and appliances
DE19603977A1 (en) Process for cleaning and disinfecting sensitive medical devices
DE60219403T2 (en) Process for the preparation of a disinfecting composition, disinfection method for medical devices
DE10030946A1 (en) Cleaning and disinfection systems for medical instruments
EP1126012B1 (en) Cleaning and sanitizing systems for medical devices
EP1126013B2 (en) Cleaning composition for medical devices
DE69116497T2 (en) Combined two-stage process for cleaning and disinfecting surgical instruments
EP0994178B1 (en) Cleaning compositions and their use
DE60015867T2 (en) Aqueous solution of peracetic acid and hydrogen peroxide for the disinfection of endoscopes
DE102011077432A1 (en) Use of bispyridiniumalkanes to kill spores
DE19814829C2 (en) Water-based cleaners and disinfectants, their use and methods for automated simultaneous cleaning and disinfection of medical instruments, in particular endoscopes
EP1126014B1 (en) Cleaning and sanitizing systems for medical devices
DE60014520T2 (en) Disinfection of endoscopes with an aqueous solution of peracetic acid and hydrogen peroxide
DE2436905B2 (en) Sterile, isotonic aqueous preparation for sterilizing soft contact lenses
EP1454638B1 (en) Concentrated disinfecting composition based on quaternary ammonium compounds and their use for chemical-thermal care for instruments
EP2617867B1 (en) Method and composition for preparing medical instruments
DE102004047247B3 (en) Sterilization process for the production of implantable or transplantable biological material
EP1138203A2 (en) Disinfection systems with microbicidal activity

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17P Request for examination filed

Effective date: 20010914

AKX Designation fees paid

Free format text: AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

17Q First examination report despatched

Effective date: 20030902

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20050119

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20050119

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20050119

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050119

Ref country code: IE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20050119

Ref country code: GB

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20050119

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: GERMAN

REF Corresponds to:

Ref document number: 50105092

Country of ref document: DE

Date of ref document: 20050224

Kind code of ref document: P

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20050419

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20050419

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20050419

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20050430

NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
GBV Gb: ep patent (uk) treated as always having been void in accordance with gb section 77(7)/1977 [no translation filed]

Effective date: 20050119

REG Reference to a national code

Ref country code: IE

Ref legal event code: FD4D

PLBI Opposition filed

Free format text: ORIGINAL CODE: 0009260

PLAX Notice of opposition and request to file observation + time limit sent

Free format text: ORIGINAL CODE: EPIDOSNOBS2

26 Opposition filed

Opponent name: ECOLAB INC.

Effective date: 20050929

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: BOVARD AG PATENTANWAELTE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20060131

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20060131

EN Fr: translation not filed
PLAS Information related to reply of patent proprietor to notice(s) of opposition deleted

Free format text: ORIGINAL CODE: EPIDOSDOBS3

PLBB Reply of patent proprietor to notice(s) of opposition received

Free format text: ORIGINAL CODE: EPIDOSNOBS3

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: BODE CHEMIE GMBH & CO. KG

BECN Be: change of holder's name

Owner name: BODE CHEMIE G.M.B.H. & CO. K.G.

Effective date: 20050119

REG Reference to a national code

Ref country code: CH

Ref legal event code: PFA

Owner name: BODE CHEMIE GMBH & CO. KG

Free format text: BODE CHEMIE GMBH & CO.#MELANCHTHONSTRASSE 27#22525 HAMBURG (DE) -TRANSFER TO- BODE CHEMIE GMBH & CO. KG#MELANCHTHONSTRASSE 27#22525 HAMBURG (DE)

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20050119

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20050119

REG Reference to a national code

Ref country code: CH

Ref legal event code: PFA

Owner name: BODE CHEMIE GMBH

Free format text: BODE CHEMIE GMBH & CO. KG#MELANCHTHONSTRASSE 27#22525 HAMBURG (DE) -TRANSFER TO- BODE CHEMIE GMBH#MELANCHTHONSTRASSE 27#22525 HAMBURG (DE)

APBM Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOSNREFNO

APBP Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2O

APAH Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNO

APBM Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOSNREFNO

APBP Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2O

APBQ Date of receipt of statement of grounds of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA3O

APBQ Date of receipt of statement of grounds of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA3O

PLAB Opposition data, opponent's data or that of the opponent's representative modified

Free format text: ORIGINAL CODE: 0009299OPPO

PLAB Opposition data, opponent's data or that of the opponent's representative modified

Free format text: ORIGINAL CODE: 0009299OPPO

R26 Opposition filed (corrected)

Opponent name: ECOLAB INC.

Effective date: 20050929

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: BODE CHEMIE GMBH

REG Reference to a national code

Ref country code: CH

Ref legal event code: PFA

Owner name: BODE CHEMIE GMBH

Free format text: BODE CHEMIE GMBH#MELANCHTHONSTRASSE 27#22525 HAMBURG (DE) -TRANSFER TO- BODE CHEMIE GMBH#MELANCHTHONSTRASSE 27#22525 HAMBURG (DE)

APBU Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9O

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20050119

PLAY Examination report in opposition despatched + time limit

Free format text: ORIGINAL CODE: EPIDOSNORE2

PLBC Reply to examination report in opposition received

Free format text: ORIGINAL CODE: EPIDOSNORE3

PUAH Patent maintained in amended form

Free format text: ORIGINAL CODE: 0009272

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: PATENT MAINTAINED AS AMENDED

27A Patent maintained in amended form

Effective date: 20130327

AK Designated contracting states

Kind code of ref document: B2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

REG Reference to a national code

Ref country code: CH

Ref legal event code: AELC

REG Reference to a national code

Ref country code: DE

Ref legal event code: R102

Ref document number: 50105092

Country of ref document: DE

Effective date: 20130327

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20180125

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20180122

Year of fee payment: 18

Ref country code: BE

Payment date: 20180124

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20190124

Year of fee payment: 19

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 287442

Country of ref document: AT

Kind code of ref document: T

Effective date: 20190103

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20190131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190131

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190103

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190131

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 50105092

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200801